Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Ibrutinib> ?p ?o }
- Ibrutinib abstract "Ibrutinib (USAN, also known as PCI-32765 and marketed under the name Imbruvica) is an anticancer drug targeting B-cell malignancies. It is an orally-administered, selective and covalent inhibitor of the enzyme Bruton's tyrosine kinase (BTK).Ibrutinib developed by Pharmacyclics, Inc and Johnson & Johnson's Janssen Pharmaceutical division for additional B-cell malignancies including diffuse large B-cell lymphoma and multiple myeloma.It was approved by the US Food and Drug Administration (FDA) in November 2013 for the treatment of mantle cell lymphoma and in February 2014 for the treatment of chronic lymphocytic leukemia.In January 2015, ibrutinib was approved by the FDA for treatment of Waldenström's macroglobulinemia, a form of non-Hodgkin's lymphoma. According to the Wall Street Journal by January 2016 isbrutinib, a specialty drug, cost US$116,600 to $155,400 a year wholesale in the United States. In spite of discounts and medical insurance, the prohibitive price causes some patients to not fill their prescriptions. The company marketing the drug, AbbVie, did not develop the drug but acquired it through an acquisition in May 2015. AbbVie estimates global sales of the drug at US$1 billion in 2016 and $5 billion in 2020.".
- Ibrutinib thumbnail Ibrutinib.svg?width=300.
- Ibrutinib wikiPageExternalLink ?CdrID=638648.
- Ibrutinib wikiPageExternalLink www.imbruvica.com.
- Ibrutinib wikiPageID "33997988".
- Ibrutinib wikiPageLength "14471".
- Ibrutinib wikiPageOutDegree "35".
- Ibrutinib wikiPageRevisionID "704234988".
- Ibrutinib wikiPageWikiLink AbbVie_Inc..
- Ibrutinib wikiPageWikiLink Arthritis.
- Ibrutinib wikiPageWikiLink B-cell_chronic_lymphocytic_leukemia.
- Ibrutinib wikiPageWikiLink Brutons_tyrosine_kinase.
- Ibrutinib wikiPageWikiLink CYP2D6.
- Ibrutinib wikiPageWikiLink CYP3A.
- Ibrutinib wikiPageWikiLink Capsule_(pharmacy).
- Ibrutinib wikiPageWikiLink Category:Breakthrough_therapy.
- Ibrutinib wikiPageWikiLink Category:Experimental_cancer_drugs.
- Ibrutinib wikiPageWikiLink Category:Phenol_ethers.
- Ibrutinib wikiPageWikiLink Category:Piperidines.
- Ibrutinib wikiPageWikiLink Category:Pyrazolopyrimidines.
- Ibrutinib wikiPageWikiLink Category:Tyrosine_kinase_inhibitors.
- Ibrutinib wikiPageWikiLink Celera_Corporation.
- Ibrutinib wikiPageWikiLink Creatinine.
- Ibrutinib wikiPageWikiLink Cysteine.
- Ibrutinib wikiPageWikiLink Diffuse_large_B-cell_lymphoma.
- Ibrutinib wikiPageWikiLink Drug_development.
- Ibrutinib wikiPageWikiLink Enzyme_inhibitor.
- Ibrutinib wikiPageWikiLink Food_and_Drug_Administration.
- Ibrutinib wikiPageWikiLink In_vivo.
- Ibrutinib wikiPageWikiLink Janssen_Pharmaceutica.
- Ibrutinib wikiPageWikiLink Johnson_&_Johnson.
- Ibrutinib wikiPageWikiLink Lymphoid_leukemia.
- Ibrutinib wikiPageWikiLink Mantle_cell_lymphoma.
- Ibrutinib wikiPageWikiLink Michael_reaction.
- Ibrutinib wikiPageWikiLink Multiple_myeloma.
- Ibrutinib wikiPageWikiLink National_Cancer_Institute.
- Ibrutinib wikiPageWikiLink Specialty_drugs_(United_States).
- Ibrutinib wikiPageWikiLink The_Wall_Street_Journal.
- Ibrutinib wikiPageWikiLink Thrombocytopenia.
- Ibrutinib wikiPageWikiLink United_States_Adopted_Name.
- Ibrutinib wikiPageWikiLink Waldenstrxc3xb6ms_macroglobulinemia.
- Ibrutinib wikiPageWikiLinkText "Ibrutinib".
- Ibrutinib wikiPageWikiLinkText "ibrutinib".
- Ibrutinib atcPrefix "L01".
- Ibrutinib atcSuffix "XE27".
- Ibrutinib c "25".
- Ibrutinib casNumber "936563".
- Ibrutinib chebi "76612".
- Ibrutinib chembl "1873475".
- Ibrutinib chemspiderid "26637187".
- Ibrutinib eliminationHalfLife "-21600.0".
- Ibrutinib excretion "Feces , urine".
- Ibrutinib h "24".
- Ibrutinib iupacName "1".
- Ibrutinib iupharLigand "6912".
- Ibrutinib kegg "D10223".
- Ibrutinib legalStatus "Rx-only".
- Ibrutinib legalUs "Rx-only".
- Ibrutinib licenceUs "Ibrutinib".
- Ibrutinib metabolism "Hepatic".
- Ibrutinib molecularWeight "440.4971".
- Ibrutinib n "6".
- Ibrutinib o "2".
- Ibrutinib pregnancyUs "D".
- Ibrutinib proteinBound "97.3".
- Ibrutinib pubchem "24821094".
- Ibrutinib routesOfAdministration "Oral".
- Ibrutinib smiles "C=CCN1CCC[C@H]N2C3=CCN".
- Ibrutinib stdinchi "1".
- Ibrutinib stdinchikey "XYFPWWZEPKGCCK-GOSISDBHBU".
- Ibrutinib tradename "Imbruvica".
- Ibrutinib unii "1".
- Ibrutinib width "200".
- Ibrutinib wikiPageUsesTemplate Template:Colbegin.
- Ibrutinib wikiPageUsesTemplate Template:Colend.
- Ibrutinib wikiPageUsesTemplate Template:Extracellular_chemotherapeutic_agents.
- Ibrutinib wikiPageUsesTemplate Template:Infobox_drug.
- Ibrutinib wikiPageUsesTemplate Template:Reflist.
- Ibrutinib subject Category:Breakthrough_therapy.
- Ibrutinib subject Category:Experimental_cancer_drugs.
- Ibrutinib subject Category:Phenol_ethers.
- Ibrutinib subject Category:Piperidines.
- Ibrutinib subject Category:Pyrazolopyrimidines.
- Ibrutinib subject Category:Tyrosine_kinase_inhibitors.
- Ibrutinib hypernym Drug.
- Ibrutinib type ChemicalSubstance.
- Ibrutinib type Drug.
- Ibrutinib type Drug.
- Ibrutinib type Ether.
- Ibrutinib type Heterocycle.
- Ibrutinib type Inhibitor.
- Ibrutinib type ChemicalObject.
- Ibrutinib type Thing.
- Ibrutinib type Q8386.
- Ibrutinib comment "Ibrutinib (USAN, also known as PCI-32765 and marketed under the name Imbruvica) is an anticancer drug targeting B-cell malignancies.".
- Ibrutinib label "Ibrutinib".
- Ibrutinib sameAs Q5984881.
- Ibrutinib sameAs Ibrutinib.
- Ibrutinib sameAs Ibrutinib.
- Ibrutinib sameAs ایبروتینیب.